Linking the anti-inflammatory and anticoagulant properties, the natural inhibitor EcTI impairs the physiopathological aspects of thrombosis

ISTH Academy, Bruno Salu, 263793

ADAMTS13 levels correlate with Renal and Inflammatory Markers in Mice with Type 1 Diabetes Mellitus and Nephropathy

ISTH Academy, Michelle Teodoro Alves, 263794

Evaluation of oral anticoagulation-associated intracerebral hemorrhage induced by collagenase VII-S in rats

ISTH Academy, Roberto Fonseca, 263795

EVALUATION OF TWO EXPERIMENTAL MODELS OF DEEP VENOUS THROMBOSIS IN RATS

ISTH Academy, Neiva Pereira Paim, 263796

Clinical implications of antivenom failures to neutralise coagulotoxicity of African snake venoms

ISTH Academy, Bryan Fry, 263811

The clinical implications of the differential coagulopathic effects of Asian pit viper snake venoms

ISTH Academy, Jordan Debono, 263812

An overview of coagulation disturbances caused by Australian Elapid snake venoms

ISTH Academy, Christina Zdenek, 263813

Coagulotoxic activity in venoms from coral snakes of the Americas (genus: Micrurus)

ISTH Academy, Daniel Dashevsky, 263814

Polyphosphate, Zn2+ and high-molecular-weight kininogen modulate individual reactions of the contact pathway of blood clotting

ISTH Academy, Yuqi Wang, 263829

Binding of activated factor XI to the platelet surface facilitates the activation of factor IX

ISTH Academy, Stephanie Elena Reitsma, 263830

Role of N-glycosylation on the secretion, plasma levels and function of Factor XII: results from patients with congenital disorders of glycosylation and a recombinant model

ISTH Academy, Maria Eugenia de la Morena-Barrio, 263831

A novel antithrombotic coating for blood-contacting medical devices

ISTH Academy, Lucia Musumeci, 263832

Interpretation of Maximum Absorbance Data Obtained from Turbidimetry in Plasma Samples

ISTH Academy, Marlien Pieters, 263846

The Comparability Evaluation and Improvement Study of Fibrinogen Measurement

ISTH Academy, Mingting Peng, 263847

Fibrin γ-chain cross-linking increases clot elastic modulus and protects against embolization as demonstrated in a new genetically modified murine model

ISTH Academy, Robert Ariëns, 263848

Genetic abnormalities of Japanese patient with symptomatic- and asymptomatic-dysfibrinogenemia

ISTH Academy, Shogo Tamura, 263849

Conditions associated with low tPA activity are prevalent among patients with schizophrenia or schzoaffective disorder

ISTH Academy, Silvia Hoirisch-Clapauch, 263862

Temporal distribution pattern of tissue-type plasminogen activator (tPA) activity in the central nervous system (CNS) delivered via the intranasal route: implications for targeted delivery of tPA to the CNS

ISTH Academy, Fiona McCutcheon, 263863

Plasma PAI-1 and tPA contents under ischemic stroke with diabetes mellitus combination

ISTH Academy, Olha Kravchenko, 263864

Pharmacokinetic study of FⅧ in Chinese boys with hemophilia

ISTH Academy, Huang Kun, 263880

Quality of Electronic Treatment Records in Patients with Hemophilia and von Willebrand Disease

ISTH Academy, Andreas Tiede, 263881

Efficacy of short-term individualized prophylaxis guided by PK and joint evaluation in Chinese adult patients with severe hemophilia A

ISTH Academy, Xueyan Sun, 263882

Management of a paediatric patient with mild haemophilia A with High Count T-Cell acute lymphoblastic leukaemia (ALL)

ISTH Academy, Alice Wilkinson, 263896

A Retrospective, Observational Study using Specialty Pharmacy data of Rurioctocog Alfa Pegol Use in the United States

ISTH Academy, Maureen Watt, 263897

Final data from the Italian Registry on intracranial haemorrhage in haemophilia patients: EMO.REC Registry (2009-2018)

ISTH Academy, Ezio Zanon, 263898

Low dose prophylaxis regimen in children and young adults- Three years experience from Kerala, India

ISTH Academy, Neeraj Sidharthan, 263912

Marked Improvement of Analytical Resolution of Low-Level Coagulation Factor VIII and IX Measurement by Applying Model Based Analysis of Clot Waveform

ISTH Academy, Song Jaewoo, 263913

Real-world Study of Physician Practice Patterns, Efficacy and Safety of Human Cell Line-derived Recombinant Factor VIII in Adults with Hemophilia A

ISTH Academy, Haowei Sun, 263914

Efficacy and safety of rIX-FP in surgery: an update from a phase 3b extension study

ISTH Academy, Claude Négrier, 263929

HaemoValue: Development of a Set of Outcomes for Measuring Value in Persons with Haemophilia

ISTH Academy, Erna Van Balen, 263930

Adding the patient’s voice to a hemophilia-specific goal menu to facilitate Goal Attainment Scaling: a qualitative study

ISTH Academy, Michael Denne, 263931

Archeogenetics of the p.Cys38Arg variant associated with FXI deficiency: a 5,400 years old mutation identified in different southwestern European countries

ISTH Academy, Maria Eugenia de la Morena-Barrio, 263947

Congenital Factor VII deficiency: epidemiology, clinical characteristics and management. Experience of the Northern Greece Hemophilia Center

ISTH Academy, Vasileia Garypidou, 263948

Efficacy and safety of fibrinogen concentrate for treatment of bleeding, surgery or routine prophylaxis in subjects with congenital fibrinogen deficiency

ISTH Academy, Joseph Lasky, 263949

Single Centre Experience On Pediatric Rare Inherited Clotting Factor Deficiencies (RICFD) From Kingdom Of Saudi Arabia - An Impetus To Establish A National Registry

ISTH Academy, Mahasen Saleh, 263963

Generation of two HEK reporter cell lines to study localization and functional interactions of VKORC1 and VKORC1L1 in a native cell environment

ISTH Academy, Francesco Forin, 263964

Results from a Phase 3 Study of On-demand Treatment with Fibrinogen Concentrate for Acute Bleeding and Surgical Prophylaxis in Patients with Congenital Fibrinogen Deficiency

ISTH Academy, Bruce Schwartz, 263965

Investigation of the epidemiology of VWD in patients attending the Royal Hospital, Muscat, Oman

ISTH Academy, Rashid Al Ghaithi, 263980

Desmopressin plasma concentration does not correlate with VWF and FVIII response in von Willebrand disease

ISTH Academy, Jessica Heijdra, 263981

The management of patients with von Willebrand disease (VWD) undergoing surgery by using a pure plasma derived VWF is easy, efficient and safe

ISTH Academy, Jenny Goudemand, 263982

Efficacy and safety of hFVIII/VWF concentrate in a large cohort of patients with von Willebrand disease (VWD) requiring surgical procedures: the French experience

ISTH Academy, Valerie Proulle, 263996

BMI is an important determinant of VWF and FVIII levels in patients with von Willebrand disease

ISTH Academy, Ferdows Atiq, 263997

Infusion Requirements in On Demand Treatment of Bleeding Events in von Willebrand Disease (VWD): an Indirect Treatment Comparison between Recombinant von Willebrand Factor (VWF) and Plasma Derived VWF Concentrates

ISTH Academy, Björn Mellgård, 263998

DDAVP challenge test in patients with von Willebrand disease type 1 (VWD1) and low von Willebrand factor (Low VWF): analysis of 616 patients

ISTH Academy, Mara Agazzoni, 264013

The Effect of Exercise-based Cardiac Rehabilitation on Heart Rates and Oxygen Consumption in Patients with Myocardial Infarction: A Meta-Analysis

ISTH Academy, Arif Nur Akhmad, 264015

Some Haemostatic parameters, Full blood count and Relative Plasma Viscosity of blood donors in Calabar metropolis

ISTH Academy, Dorathy Chioma Okpokam, 264017

Hypofibrinogenemia: A novel long deletion of the fibrinogen beta chain causing mucocutaneous bleeding

ISTH Academy, Darintr Sosothikul, 264032

Kasabach-Merritt phenomenon in an infant: Tufted angioma or kaposiform hemangioendothelioma

ISTH Academy, Rumeysa Tuna, 264033

Impact of Hematology Involvement on Adolescents Admitted for Acute Heavy Menstrual Bleeding

ISTH Academy, Viia Anderson, 264035

Predictive Value of D-dimers in the Diagnosis of Suspected Acute Limb Deep Vein Thrombosis in Children: a Prospective Study

ISTH Academy, Leonardo Brandao, 264049

Incidence of VTE in Сhildren with Hematologic Disorders: a Monocentric Study in Russian Federation

ISTH Academy, Daria Morozova, 264050

Thromboembolism and Bleeding in Congenital Diaphragmatic Hernia

ISTH Academy, Leonardo Brandao, 264051

Evaluation Of Venous Thromboembolism In Childhood

ISTH Academy, Aylin Ayhan, 264065

Low dose anticoagulation in children with Kawasaki disease and large coronary artery aneurysms: our experience at Chandigarh, North India

ISTH Academy, Surjit Samlok, 264066

Central Venous Line Insertion in a Child with Factor VII Deficiency and Inhibitors to FVII

ISTH Academy, Dianne Marshall, 264067

Hemostatic Complications in Pediatric Extra Corporeal Membrane Oxygenation: the Role of Rotational Thromboelastometry

ISTH Academy, Joppe Drop, 264081

Congenital Protein C Deficiency: Unfamiliarity of this Condition led to Unfavorable Results in a 14 Year old Girl

ISTH Academy, Madlen Reschke, 264082

The impact of the volume of mediastinal lymphadenopathy on venous thromboembolism in children with lymphoma

ISTH Academy, Daria Fedorova, 264084

Development of an Umbilical Cord and Pediatric Plasma Bank

ISTH Academy, Helen Atkinson, 264099

Pediatric May-Thurner Syndrome - a Systematic Review

ISTH Academy, Leonardo Brandao, 264100

Pediatric Intracardiac Thrombosis : Right(venous) or Left(arterial) ?

ISTH Academy, Selin AYTAC, 264101

Altered Platelet Function in Patients with Chronic Lymphocytic Leukaemia Persists Despite Treatment with Ibrutinib or Venetoclax

ISTH Academy, Scott Russell McGregor, 264116

Anticipation of Bleeding in Aplastic Anemia using ISTH Bleeding scores and Platelet ranges: Is it Beneficial?

ISTH Academy, Naveena Fatima, 264117

Impaired health-related quality of life in patients with (suspected) congenital platelet function defects

ISTH Academy, Rolf Urbanus, 264118

The risk factors for severity of the GLATIT score during inherited platelets disorders

ISTH Academy, Reda Messaoudi, 264132

First Spanish Registry of Inherited Platelet Disorders [RETPLAC]

ISTH Academy, Jose Rivera, 264133

Identification of compound heterozygous mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with epistaxis

ISTH Academy, Guangying Sheng, 264134

PLATELET VOLUME PARAMETERS ACCORDING TO GESTATIONAL AGE

ISTH Academy, Saadet Akarsu, 264149

Immune thrombocytopenia in childhood: A 15 year single center experience

ISTH Academy, Alkistis Adramerina, 264150

Multi-level defects of the hematopoietic niche in essential thrombocythemia and the effects of Interferonα-2b on them

ISTH Academy, Ting Sun, 264151

Reinforcement of Integrin-Actin Linkages on Platelets in Response to Force

ISTH Academy, David Bark, 264166

Dependence of platelet traction forces on myosin activity and GPIb levels

ISTH Academy, Ingmar Schoen, 264167

Do donor attributes influence platelet quality following ex vivo storage?

ISTH Academy, Dianne Van Der Wal, 264168

PPAR alpha identified as a novel regulator of platelet function in vivo with possible dual regulation in atherothrombosis

ISTH Academy, Michael Holinstat, 264184

Pro-coagulant platelet formation involves ‘supramaximal’ Ca2+signalling

ISTH Academy, Nima Abbasian, 264185

Coenzyme Q10 attenuates platelet function through targeting cAMP/PKA pathway

ISTH Academy, Yan Yang, 264186

Activated platelets kill S. aureusand S. pneumoniae by FcγRIIa-independent mechanisms, which are not enhanced by Platelet factor 4/Heparin-antibodies

ISTH Academy, Martina Wolff, 264201

Inferior vena cava filters in cancer patients: Indications and outcome

ISTH Academy, Anila Rashid, 264202

A Comparison of Venous Thromboembolism (VTE) and Arterial Events between Ixazomib, Lenalidomide and Dexamthosone (ILD) and Lenalidomide and Dexamethosone (LD) chemotherapy in Multiple Myeloma: Single Centre Experience

ISTH Academy, Zara Sayar, 264203

Evaluation of outpatient management in patients with cancer-associated venous thromboembolism

ISTH Academy, Stephan Hendriks, 264218

Full Benefit Of Rivaroxaban Prophylaxis In High-Risk Ambulatory Cancer Patients: An Analysis Of All Thromboembolic Events In CASSINI

ISTH Academy, Alok Khorana, 264219

Efficacy and Safety of Rivaroxaban Thromboprophylaxis by Khorana Score Category: A Subgroup Analysis of CASSINI

ISTH Academy, Alok Khorana, 264220

Incidence of venous thromboembolism in patients with advanced stage cervico-uterine cancer

ISTH Academy, Gabriela Cesarman Maus, 264234

THE PROGNOSTIC VALUE AND CLINICAL SIGNIFICANCE OF ANTI-PHOSPHOLIPID ANTIBODIES IN PATIENTS WITH NHL

ISTH Academy, Gaurav Prakash, 264235

Venous and Arterial Thrombosis in Myeloproliferative Neoplasms

ISTH Academy, Lugyanti Sukrisman, 264236

Thromboelastometry alterations are related with multiple myeloma disease status. Results of the ROADMAP-MM-CAT study

ISTH Academy, Grigoris Gerotziafas, 264252

Efficacy outcomes and treatment pattern in patients with cancer-associated venous thromboembolism: A Korean Nationwide Venous Thromboembolism Study

ISTH Academy, Hun-Gyu Hwang, 264253

Risk and management of cancer-associated venous thromboembolism: a 10-year retrospective study in a tertiary teaching hospital in Hong Kong

ISTH Academy, Carmen Ka Man Cheung, 264254

Analysis of Bleeding Events on Prophylactic Rivaroxaban in the CASSINI Study

ISTH Academy, Gerald Soff, 264269

Risk of bleeding according to renal function in patients with venous thromboembolic disease under treatment with enoxaparin

ISTH Academy, Fernando Chuliber, 264270

Resumption of Anticoagulant Therapy After Anticoagulant-Related Bleeding: A Population-Based Cohort Study

ISTH Academy, Deborah Siegal, 264271

The Use of Direct Oral Anticoagulants in Inherited Antithrombin Deficiency

ISTH Academy, Andrew Doyle, 264287

Therapy persistence, adherence and predictors for non-adherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

ISTH Academy, Myrthe M.A. Toorop, 264288

The season role in the occurrence of thromboembolic disease

ISTH Academy, Mohamed Habib Houman, 264290

Recurrence Risk According to Anticoagulant Prescribed for the Secondary Prevention of Venous Thrombosis

ISTH Academy, Neil Zakai, 264305

Efficacy and safety of apixaban for treatment of venous thromboembolism in a daily practice-based cohort

ISTH Academy, Stephan Hendriks, 264306

A single centre retrospective review of prophylactic apixaban safety and efficacy in patients after venous thromboembolism

ISTH Academy, Dominic Pepperell, 264307

The use of apixaban or rivaroxaban in patients taking calcineurin inhibitors (CNIs): a review of therapeutic levels

ISTH Academy, Rogers Hannah, 264325

First analysis of an observational, prospective, specific registry of cancer-associated thrombosis (CAT): TESEO registry

ISTH Academy, Andres Muñoz, 264327

Direct Oral Anticoagulant (DOAC) monitoring: A real world experience

ISTH Academy, Alison Slocombe, 264328